Coronavirus: Situation in Switzerland

Data and reports on the epidemiological situation in Switzerland and Liechtenstein, press conferences and coronavirus news can all be found here.

Figures on the coronavirus situation in Switzerland and Liechtenstein

Daily report

You can download the daily report as a PDF and data in CSV or JSON format at www.covid19.admin.ch.

You can continue to receive the following data as Excel files:

• Daily report data available in German (XLS, 33 kB, 15.02.2021); French (XLS, 33 kB, 15.02.2021) or Italian (XLS, 33 kB, 15.02.2021)

• Data on laboratory findings and deaths (CSV, 124 MB, 15.02.2021)
• Data on tests conducted (XLS, 21 kB, 15.02.2021)
• Demographic data by canton and age group (XLS, 115 kB, 23.12.2020)

Weekly report

This report, published every Thursday morning, provides an informative overview of the epidemiological situation and trends.   

Week 5, 10.2.2021

Weekly report on the epidemiological situation in Switzerland and Liechtenstein available in German (PDF, 1 MB, 11.02.2021); French (PDF, 1 MB, 11.02.2021) or Italian (PDF, 1 MB, 11.02.2021)

Previous daily and weekly reports

You will find all the previous reports in the zip files specified below; daily reports since 7 March 2020, weekly reports since calendar week 25 (2nd quarter 2020)

German:
2020_Q1 (ZIP, 9 MB, 28.08.2020)
2020_Q2 (ZIP, 55 MB, 28.08.2020)
2020_Q3 (ZIP, 45 MB, 05.10.2020)
2020_Q4 (ZIP, 32 MB, 07.01.2021)

2021_Q1 (ZIP, 14 MB, 15.02.2021)

French:
2020_Q1 (ZIP, 12 MB, 28.08.2020)
2020_Q2 (ZIP, 75 MB, 28.08.2020)
2020_Q3 (ZIP, 46 MB, 05.10.2020)
2020_Q4 (ZIP, 31 MB, 07.01.2021)

2021_Q1 (ZIP, 15 MB, 15.02.2021)

Italian:
2020_Q1 (ZIP, 5 MB, 28.08.2020)
2020_Q2 (ZIP, 62 MB, 28.08.2020)
2020_Q3 (ZIP, 56 MB, 05.10.2020)
2020_Q4 (ZIP, 33 MB, 07.01.2021)

2021_Q1 (ZIP, 13 MB, 15.02.2021)

COVID-19 vaccination statistics

Twice a week, statistics on COVID-19 vaccination are published on www.covid19.admin.ch, where you’ll find the following figures:

• Vaccine doses supplied (total CH + FL and by canton)
• Vaccine doses administered (total CH + FL and by canton)
• Vaccine doses administered per 100 inhabitants

Allocation of vaccine doses to the cantons

Doses of vaccine are divided between the cantons in proportion to their population and share of especially vulnerable people (target group 1). This allocation is done on the basis of a distribution key. The distribution key for cantonal vaccine quotas was created by the Swiss Federal Institute of Technology (ETH) Zurich and the ZHAW Zurich University of Applied Sciences. The key takes account of population numbers from the Federal Statistical Office (SFSO) and the relevant target group’s share of the population. In this document you’ll find an explanation of the distribution key and an example.

In the following document you’ll find the allocation of cantonal vaccine quotas for especially vulnerable people (target group 1).

COVID-19 management: Strategic basis at federal and cantonal level

The federal government and the cantons have interrelated tasks in the management of COVID-19. This results in a need to coordinate assessments, reconcile measures and define processes. This brief strategy paper sets out to clarify the basic principles governing these issues over the months to come. The aim is to protect the health of the population in Switzerland and minimise the impact of the outbreak and spread of the coronavirus as far as possible.

COVID-19 management: Strategic bases of the Swiss Conference of the Cantonal Ministers of Public Health (GDK) and the FDHA-FOPH (in German (PDF, 768 kB, 22.10.2020) and French (PDF, 779 kB, 22.10.2020))

Monitoring and interim reports 

On the Monitoring page you will find reports on the population’s mobility behaviour, the monitoring of precautionary measures, the economic situation and compliance monitoring.

Interim report regarding the new coronavirus in Switzerland and in the Principality of Liechtenstein

The report sets out the general epidemiological situation and the impact of the measures taken by the government with regard to the new coronavirus.

COVID-19: Epidemiological interim report, dated 27 April 2020, available in German (PDF, 1 MB, 07.05.2020); French (PDF, 1 MB, 07.05.2020) or Italian (PDF, 1 MB, 07.05.2020)

Study on the spread and impact of the new coronavirus

When someone is infected with the new coronavirus, their body produces specific antibodies in the blood. Through detection of these antibodies, we can determine how many people in the population have been infected.
A nationwide long-term monitoring programme seeks to provide insights into the spread and impact of coronavirus. It is being conducted as part of Corona Immunitas, a national science programme of the Swiss School of Public Health (SSPH+).

Objectives of the programme

The detection of antibodies seeks to:

• provide evidence on the spread of coronavirus in Switzerland’s different regions and in specific population and occupational groups;
  
• provide information on whether and to what extent measures to combat the spread of coronavirus are working;
• determine whether a past infection protects from re-infection and if so, how long this protection lasts.

Surveys aim to deliver insights into the impact of coronavirus in terms of:

• our day-to-day lives in the community,
• our behaviour,
• our health.

Programme: participation, scope and duration

Fourteen universities and institutions from all over Switzerland are participating in Corona Immunitas. Over 40 studies are being conducted involving more than 30,000 Swiss residents.

Corona Immunitas will run until the end of 2021.

The FOPH is contributing to the study and providing financial support. The findings will provide an important basis to help federal and cantonal policymakers determine what measures are needed to combat the coronavirus epidemic.

Scientific advisory body

The Swiss National COVID-19 Science Task Force (SN-STF) serves as a scientific advisory body to the federal government. Its members are researchers from across the entire university landscape. The SN-STF contributes to efforts to manage the coronavirus pandemic by making its scientific and research expertise available to the political authorities responsible.

The task force is headed by Professor Martin Ackermann (ETH Zurich and Eawag) together with a steering committee comprising Professor Manuel Battegay (University of Basel), Professor Monika Bütler (University of St. Gallen) and Professor Samia Hurst (University of Geneva).

The SN-STF has been mandated by the Federal Department of Home Affairs (FDHA) and the FOPH.

Further information may be found on the website of the Swiss National COVID-19 Science Task Force.